Cholera: Individualised risk assessment for travellers

+Practice
In print
Travel medicine

Cholera: Individualised risk assessment for travellers

By Jenny Visser
Toilet_Rolls
Cholera is considered a low-incidence disease in travellers, but the true impact is difficult to assess [Image: Erik Mclean on Unsplash]

This article summarises three papers about cholera, including the global situation, a new vaccine on its way, and guidelines on who should get vaccinated

This Practice article has been endorsed by the RNZCGP and has been approved for up to 0.25 credits for continuing professional development purposes (1, Educate small, BACK panel - grey
References

1. WHO. Multi-country outbreak of cholera. External Situation Report n. 15. 19 June 2024.

2. Levine MM, Chen WH, Kaper JB, et al. PaxVax CVD 103-HgR single-dose live oral cholera vaccine. Expert Rev Vaccines 2017;16(3):197–213.

3. López-Vélez R, Presotto D. Cholera in travellers: improving vaccination guidance in Europe. J Travel Med 2021;28(1):taaa209.